这里是《21健讯Daily》,欢迎与21世纪经济报道新健康团队共同关注医药健康行业最新事件!政策动向小儿感冒宁颗粒和蒲公英颗粒转换为非处方药5月27日,国家药监局公告称,根据《处方药与非处方药分类管理办法(试行)》(原国家药品监督管理局令第10号)规定,经国家药监局组织论证和审核,小儿感冒宁颗粒和蒲公英颗粒由处方药转换为非处方药。药械审批卫材抗失眠新药莱博雷生在中国获批上市5月27日,卫材(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.